DK1009439T3 - Polymer-platin-forbindelser - Google Patents

Polymer-platin-forbindelser

Info

Publication number
DK1009439T3
DK1009439T3 DK98918020T DK98918020T DK1009439T3 DK 1009439 T3 DK1009439 T3 DK 1009439T3 DK 98918020 T DK98918020 T DK 98918020T DK 98918020 T DK98918020 T DK 98918020T DK 1009439 T3 DK1009439 T3 DK 1009439T3
Authority
DK
Denmark
Prior art keywords
polymer
platinum compounds
platinum
compound
backbone
Prior art date
Application number
DK98918020T
Other languages
English (en)
Inventor
Ruth Duncan
Evagoras G Evagorou
Robert G Buckley
Elisabetta Gianasi
Original Assignee
Access Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Access Pharma Inc filed Critical Access Pharma Inc
Application granted granted Critical
Publication of DK1009439T3 publication Critical patent/DK1009439T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98918020T 1997-04-18 1998-04-15 Polymer-platin-forbindelser DK1009439T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4474397P 1997-04-18 1997-04-18
PCT/US1998/006770 WO1998047537A1 (en) 1997-04-18 1998-04-15 Polymer-platinum compounds

Publications (1)

Publication Number Publication Date
DK1009439T3 true DK1009439T3 (da) 2003-05-05

Family

ID=21934085

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98918020T DK1009439T3 (da) 1997-04-18 1998-04-15 Polymer-platin-forbindelser

Country Status (12)

Country Link
US (1) US5965118A (da)
EP (1) EP1009439B1 (da)
JP (2) JP4536165B2 (da)
AT (1) ATE230613T1 (da)
AU (1) AU736297B2 (da)
CA (1) CA2286091C (da)
DE (1) DE69810636T2 (da)
DK (1) DK1009439T3 (da)
ES (1) ES2194312T3 (da)
TW (1) TW509573B (da)
WO (1) WO1998047537A1 (da)
ZA (1) ZA983250B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2396702C (en) * 2000-01-04 2010-03-23 Access Pharmaceuticals, Inc. N,o-amidomalonate platinum complexes
US7166733B2 (en) * 2000-01-04 2007-01-23 Access Pharmaceuticals, Inc. O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes
AU2006222657B2 (en) * 2000-01-04 2009-01-15 Access Pharmaceuticals, Inc. N,O-amidomalonate platinum complexes
WO2002020663A2 (en) 2000-09-06 2002-03-14 Ap Pharma, Inc. Degradable polyacetal polymers
SG92833A1 (en) 2001-03-27 2002-11-19 Sumitomo Chemical Co Polymeric light emitting substance and polymer light emitting device using the same
KR100484504B1 (ko) * 2001-09-18 2005-04-20 학교법인 포항공과대학교 쿠커비투릴 유도체를 주인 분자로서 포함하고 있는 내포화합물 및 이를 포함한 약제학적 조성물
US7754684B2 (en) * 2003-06-11 2010-07-13 Access Pharmaceuticals, Inc. Macromolecular platinum chelates
CA2631704A1 (en) 2005-12-05 2007-06-14 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
US20080279782A1 (en) * 2007-05-09 2008-11-13 Nitto Denko Corporation Polymers conjugated with platinum drugs
JP2012505228A (ja) * 2008-10-07 2012-03-01 レクサン ファーマシューティカルズ インコーポレイテッド Hpma−ドセタキセルまたはゲムシタビンコンジュゲートおよびその使用
BR112012008772A2 (pt) * 2009-10-13 2017-06-20 Rexahn Pharmaceuticals Inc sistemas poliméricos para a liberação de agentes anti-câncer
EP2743273A1 (de) 2012-12-12 2014-06-18 Umicore AG & Co. KG Verfahren zur Herstellung wasserhaltiger Zubereitungen von Komplexen der Platingruppenmetalle

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS173846B1 (da) * 1974-04-23 1977-03-31
CS173849B1 (da) * 1974-04-25 1977-03-31
IL73972A0 (en) * 1984-12-31 1985-03-31 Yeda Res & Dev Agents based on platinum compounds
GB8500209D0 (en) * 1985-01-04 1985-02-13 Ceskoslovenska Akademie Ved Synthetic polymeric drugs
IN165717B (da) * 1986-08-07 1989-12-23 Battelle Memorial Institute
US4931553A (en) * 1988-05-11 1990-06-05 Gill Devinder S Platinum-polymer complexes and their use as antitumor agents
US5420105A (en) * 1988-09-23 1995-05-30 Gustavson; Linda M. Polymeric carriers for non-covalent drug conjugation
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents
US5484584A (en) * 1990-10-02 1996-01-16 Board Of Regents, The University Of Texas System Therapeutic and diagnostic use of modified polymeric microcapsules
GB9026491D0 (en) * 1990-12-05 1991-01-23 Erba Carlo Spa Anthracycline-conjugates
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
GB9213077D0 (en) * 1992-06-19 1992-08-05 Erba Carlo Spa Polymerbound taxol derivatives
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
KR0164460B1 (ko) * 1995-10-02 1999-03-20 김은영 고분자 백금 착화합물, 그의 제조방법 및 그를 유효성분으로 하는 항암제

Also Published As

Publication number Publication date
DE69810636T2 (de) 2003-11-06
DE69810636D1 (de) 2003-02-13
CA2286091C (en) 2010-07-06
EP1009439A1 (en) 2000-06-21
ZA983250B (en) 1998-10-18
ATE230613T1 (de) 2003-01-15
WO1998047537A1 (en) 1998-10-29
TW509573B (en) 2002-11-11
JP4536165B2 (ja) 2010-09-01
CA2286091A1 (en) 1998-10-29
EP1009439B1 (en) 2003-01-08
ES2194312T3 (es) 2003-11-16
JP2010132685A (ja) 2010-06-17
AU7102698A (en) 1998-11-13
US5965118A (en) 1999-10-12
JP2001524098A (ja) 2001-11-27
AU736297B2 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
PT927150E (pt) Compostos de lipoxina e sua utilizacao no tratamento de doencas proliferativas celulares
NO20001405D0 (no) Modifisert alumoksan-katalysatoraktivator
DE69623927D1 (de) Russzusammensetzungen und verbesserte polymerzusammensetzungen
DK1009439T3 (da) Polymer-platin-forbindelser
ID23953A (id) Asam 5-alkil-2-arilaminofenilasetat dan turunannya
DE68910714D1 (de) Modifizierter Dienpolymerkautschuk.
DE59705681D1 (de) Katalytisch wirksame aktivatorkomplexe mit n 4?-liganden für persauerstoffverbindungen
BR9711586A (pt) Compostos e uso dos mesmo
DE68900305D1 (de) Kammerbuegel und baum fuer sattel.
ATE185066T1 (de) Lösung zur verwendung gegen den pilzbefall von nägeln
ID21863A (id) Senyawa kinolin dan kinazolin yangberguna dalam terapi, khususnya dalam pengobatan heperplasia prostatik jinak
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
KR900009778A (ko) 아미드 측-쇄 중합체
CY1109221T1 (el) Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
BR8907490A (pt) Silencioso de escape
BR9907025B1 (pt) Polissacarídeos sintéticos e uso dos mesmos
BR9709720A (pt) Formamidas, acetamidas e propionamidas indezil benzilideno substituìdas
TR199801452T2 (xx) Jinekolojik rahats�zl�klar�n tedavisinde kullan�lan LHRH analoglar� ve anti�strojenlerden m�te�ekkil farmakolojik kombine madde.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
DE69729768D1 (de) Herzschrittmacher mit Bestimmung des anaeroben Schwellwertes
ID17999A (id) Amida-amida asam alpha-amino, permbuatan dan penggunaannya secara terapi
ID22688A (id) Polimerisasi yang dikatalisa oleh asam dan diperbaiki
DE58907235D1 (de) Polymerisatmischung.
DE69014980T2 (de) Biegsames Schiebeblatt und Gehäuse dazu.